Hyperscale data centers are built, operated, and maintained to process a vast quantity of customer and business data. The number of people accessing the internet has grown significantly in the past decade, increasing from about 1.5 billion in 2008 to 4.1 billion in 2017. Consequently, the amount of data generated has also grown by over 50 times because of the increased use of desktop systems, smartphone penetration, social media, wearable devices, and connected devices.

Iran's pharmaceutical market has entered a state of limbo after the re-imposition of sanctions halted the upswing momentum after their removal in 2016. The country's pharmaceutical expenditure valued at IRR90,803bn (USD2.26bn) in 2017. A lack of quality and reliable information is a problem associated with assessing Iran's pharmaceutical market and there is no data available regarding the split between patented and generic medicines. Due to the now-removed international sanctions, generic medicines have commanded the highest market share, and this will remain so at least over the short-to-medium term. Per capita spending on pharmaceuticals was a mere USD28 in 2017, among the lowest regionally.

The Ministry of Energy and Mineral Resources is responsible for policy formation and implementation in the field of energy and mineral resources, including oil and gas. Special Task Force for Upstream Oil and Gas Business Activities is an institution established by the Government of the Republic of Indonesia in 2013 to manage the upstream oil and gas business activities. National oil company Pertamina maintains a dominant position over all oil and gas up activities in the country, holds operatorship of all of Indonesia's refineries, and is the sole buyer of crude oil in Indonesia.

Second smallest market in the CEE region. Per capita spending is well below the CEE average. Market will record moderate single-digit CAGR in local currency terms. Consumables and other medical devices have the largest market shares. Most requirements need to be imported; the US and Germany are major partners. Weak and undercapitalised domestic production sector. Relatively strong hospital sector, although the need for modernisation is great. EU negotiations began in December 2015; 12 chapters have been opened to date. 

Eighth largest market in the CEE region. Per capita spending is the fifth highest in the region. Market will record a high single-digit CAGR in local currency and US dollar terms. Consumables and orthopaedics & prosthetics have the largest market shares. The market is heavily reliant on imports in most sectors, as local manufacturing capacity is more geared to exports. Longstanding local production of dental apparatus. Comprehensive public health insurance system introduced in 1993. Relatively underdeveloped private sector.

The market study for silicone is segmented on the basis of product, application and region. In terms of product, the silicone industry is segmented into four levels including fluids, gels, resin, elastomers and other products. Furthermore, we have drilled down the silicone fluids product segment into modified and straight ones. The market study for silicone elastomers is further segmented into high temperature vulcanized (HTV), Room temperature vulcanized (RTV) and liquid silicone rubber (LSR). We have covered the silicone based products including, wax, caulks and emulsions under the other product segments. We have covered the quantitative analysis on silicone market in major applications including, electrical & electronics, transportation, construction, personal care & pharmaceuticals, and textile industries. Furthermore, we have covered the use of silicone in food & beverage, oil & gas, chemicals, and consumer goods sectors only.

Small but sophisticated medical device market. Imports supply most of the market. Other medical devices and diagnostic imaging have the largest market shares. High per capita spending in the Middle East Africa region. Double- digit market CAGR driven by the National Health Strategy.

The market is the eighth largest in our Asia Pacific (APAC) region and ranks among the top 30 in the world.  Per capita spending is above average for the APAC region but close to the global average. Other medical devices has the largest market share, while the markets for dental products and orthopaedics & prosthetics remain underdeveloped. The market will see moderate growth in local currency terms and higher growth in US dollar terms due to the appreciatory trend of the MYR. Despite an expanding manufacturing industry, the market remains heavily dependent on imports in most product sectors. Malaysia is a net exporter of medical devices, due to a large trade surplus for rubber based products such as surgical gloves and catheters, and more recently other portable aids. Healthcare expenditure is near evenly split between public and private sector. The private sector is the main purchaser of high-tech equipment.

Micro-perforated food packaging is a type of perforated packaging that contains micro holes, which enable gas permeation in order to maintain the rate of respiration of food products. Micro-perforation involves the puncturing of packaging films with holes ranging from a diameter of 30 mm to 200 mm. This packaging offers various advantages including extended shelf life and moisture retention of the food products. We have segmented the global micro-perforated food packaging market based on three parameters, namely material, application, and region. In terms of material, micro-perforated food packaging market has been segmented into polyethylene (PE), Polypropylene (PP), polyethylene terephthalate (PET), and others. Others include Polyvinyl chloride (PVC) and Ethylene vinyl alcohol (EVOH). These materials are used in various types of plastic packaging such as wraps, bags, pouches, and sleeves.

The medical device testing services include biocompatibility studies, chemistry studies, microbiological & sterility testing, and package validation services. The demand for all these services is expected to rise owing to growing trend of outsourcing in preclinical and clinical phase of R&D by medical device companies.